Amid questions about the safety of the HPV vaccine Gardasil one of the lead researchers for the Merck drug is speaking out about its risks, benefits and aggressive marketing. Dr. Diane Harper says ...

The HPV vaccine is very safe and highly effective at preventing cervical cancer, according to two large reviews that support ...

How long is a drugmaker willing to wait on an indication expansion plan? For Merck’s HPV vaccines, that's 10 years. Merck won the FDA “priority review” designation for an application to expand ...

The FDA has approved Gardasil, a vaccine that targets the virus responsible for most cervical cancers and genital warts. Here are 12 questions and answers on the new vaccine. 1. What is Gardasil?

The human papillomavirus (HPV) vaccine Gardasil is not linked to an increased risk of multiple sclerosis or any other similar central nervous system conditions, found a study published in JAMA today.

Merck MRK continues to face challenges with Gardasil, its second-largest product, which is a vaccine approved for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s ...

Merck & Co. won’t be able to fully meet global demand for HPV vaccine Gardasil until after 2023 when it completes production of a couple of manufacturing plants. So for now, the drugmaker is again ...

Merck HPV vaccine Gardasil is poised for major growth by 2025 as new geographies and expanded labels add more people to its patient pool. Although the vaccine is 12 years old, Wolfe Research analysts ...

Gardasil is a vaccine that is administered to prevent certain strains of human papillomavirus (HPV). Several strains of HPV exist, many of which are harmless and only cause infections that clear up on ...

FDA panel recommends approval for Gardasil in boys but experts advise caution. Sept. 11, 2009 — -- Gynecologists and pediatricians largely supported a U.S. Food and Drug Administration advisory ...

Immigrant girls required to take controversial vaccine but not American teens. Sept. 11, 2009— -- Born in Britain in 1992, Simone Davis got off to a rough start in life. Her biological mother ...